Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients

被引：1
|
作者：
Coyne, Kathryn [1 ]
Silverman, Paula [2 ]
Liu, James H. [1 ]
机构：
[1] Univ Hosp Cleveland, Univ Hosp MacDonald Womens Hosp, Dept Obstet & Gynecol, Med Ctr, Cleveland, OH 44106 USA
[2] Univ Hosp Seidman, Dept Med, Canc Ctr, Cleveland, OH USA
来源：
CLINICAL BREAST CANCER | 2020年 / 20卷 / 05期
关键词：
Elagolix; GnRH agonist; GnRH antagonist; Ovarian suppression; Premenopausal; PREMENOPAUSAL WOMEN; HUMAN SERUM; TESTOSTERONE; ESTRADIOL; THERAPY;
D O I：
10.1016/j.clbc.2020.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E551 / E554
页数：4
相关论文
共 50 条
  • [1] Controlled ovarian stimulation with gonadotrophins, GnRH antagonist and GnRH agonist in patients with IVF and ICSI after TESE
    Schill, T
    Felberbaum, R
    Al-Hasani, S
    Bals-Pratsch, M
    Diedrich, K
    [J]. HUMAN REPRODUCTION, 1998, 13 : 319 - 319
  • [2] Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
    Stimpfel, Martin
    Vrtacnik-Bokal, Eda
    Pozlep, Barbara
    Virant-Klun, Irma
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [3] Ovarian suppression failure during GnRH agonist treatment: A report of three breast cancer patients
    de Ciantis, M.
    Faure, C.
    Heudel, P-E
    Tredan, O.
    Rousset-Jablonski, C.
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (06) : 261 - 264
  • [4] GnRH agonist trigger after GnRH antagonist cotreatment for prevention of OHSS in patients with polycystic ovarian syndrome (PCOS).
    Engmann, L.
    Tuccillo, C.
    Schmidt, D.
    Nulsen, J.
    Maier, D.
    Benadiva, C.
    [J]. FERTILITY AND STERILITY, 2006, 86 : S460 - S461
  • [5] Comparison of the luteal phase after pituitary suppression with GnRH-agonist versus GnRH antagonist in controlled ovarian hyperstimulation.
    Willman, SP
    Kliman, HJ
    [J]. FERTILITY AND STERILITY, 2005, 84 : S308 - S308
  • [6] GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate
    Orvieto, Raoul
    Patrizio, Pasquale
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2013, 26 (01) : 4 - 8
  • [7] GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity
    Orvieto, Raoul
    Meltzer, Simion
    Rabinson, Jacob
    Zohav, Efraim
    Anteby, Eyal Y.
    Nahum, Ravit
    [J]. FERTILITY AND STERILITY, 2008, 90 (04) : 1294 - 1296
  • [8] Efficacy of treatment with a GnRH antagonist in prostate cancer patients previously treated with a GnRH agonist
    Taisuke Ezaki
    Takeo Kosaka
    Ryuichi Mizuno
    Toshiaki Shinojima
    Eiji Kikuchi
    Akira Miyajima
    Mototsugu Oya
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 301 - 306
  • [9] Comparison of GnRH agonist and GnRH antagonist in ovarian stimulation of oocyte donors.
    de la Llata, ES
    Moraga, SMR
    Batiza, RV
    Santos, HR
    Galache, VP
    Hernández-Ayup, S
    Patrizio, P
    [J]. FERTILITY AND STERILITY, 2003, 80 : S185 - S185
  • [10] Efficacy of treatment with a GnRH antagonist in prostate cancer patients previously treated with a GnRH agonist
    Ezaki, Taisuke
    Kosaka, Takeo
    Mizuno, Ryuichi
    Shinojima, Toshiaki
    Kikuchi, Eiji
    Miyajima, Akira
    Oya, Mototsugu
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 301 - 306
12345